The Manufacturers Life Insurance Company Makes New Investment in Aehr Test Systems $AEHR

Key Points

• The Manufacturers Life Insurance Company acquired 7,856 Aehr Test Systems shares in the first quarter, worth approximately $291,000. Institutional investors collectively own 69.69% of AEHR.
• Aehr is benefiting from strong AI-related demand, including a $22 million follow-on order, record quarterly bookings of $60.7 million, a backlog of about $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million.
• Analyst sentiment remains broadly positive, with a consensus “Buy” rating and $136.67 price target, although insider selling and concerns about AEHR’s elevated valuation and ability to meet high growth expectations present risks.

The Manufacturers Life Insurance Company bought a new position in Aehr Test Systems (NASDAQ:AEHR - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 7,856 shares of the semiconductor company's stock, valued at approximately $291,000.

Other institutional investors have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Aehr Test Systems during the 4th quarter valued at approximately $25,000. Sunbelt Securities Inc. acquired a new position in Aehr Test Systems in the third quarter worth $27,000. State of Wyoming acquired a new position in Aehr Test Systems in the second quarter worth $28,000. KBC Group NV bought a new stake in Aehr Test Systems during the first quarter valued at $30,000. Finally, Russell Investments Group Ltd. increased its stake in Aehr Test Systems by 3,500.0% during the third quarter. Russell Investments Group Ltd. now owns 2,448 shares of the semiconductor company's stock valued at $74,000 after purchasing an additional 2,380 shares during the last quarter. 69.69% of the stock is currently owned by institutional investors.

More Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1x1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Craig Hallum reissued a "buy" rating and set a $125.00 target price on shares of Aehr Test Systems in a report on Wednesday, July 15th. Zacks Research raised shares of Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a report on Friday, July 17th. Weiss Ratings downgraded shares of Aehr Test Systems from a "sell (d)" rating to a "sell (e+)" rating in a research report on Wednesday, July 29th. Jefferies Financial Group started coverage on shares of Aehr Test Systems in a research note on Thursday. They set a "buy" rating and a $175.00 price objective on the stock. Finally, Wall Street Zen raised shares of Aehr Test Systems from a "sell" rating to a "hold" rating in a report on Saturday, July 18th. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Aehr Test Systems currently has a consensus rating of "Buy" and a consensus price target of $136.67.

Aehr Test Systems Price Performance

Shares of AEHR opened at $134.06 on Monday. Aehr Test Systems has a 12 month low of $16.38 and a 12 month high of $147.40. The stock has a fifty day moving average price of $92.83 and a 200 day moving average price of $71.76. The company has a market cap of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10.

Insider Activity at Aehr Test Systems

In related news, CEO Gayn Erickson sold 40,000 shares of Aehr Test Systems stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $130.84, for a total value of $5,233,600.00. Following the sale, the chief executive officer directly owned 157,723 shares in the company, valued at $20,636,477.32. This trade represents a 20.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Alberto Salamone sold 9,672 shares of Aehr Test Systems stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $127.72, for a total transaction of $1,235,307.84. Following the completion of the sale, the executive vice president owned 41,962 shares in the company, valued at approximately $5,359,386.64. This represents a 18.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 109,475 shares of company stock valued at $13,827,160. Company insiders own 6.80% of the company's stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source